Advanced search
Publication Cover
COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 8, 2011 - Issue 1
Submit an article Journal homepage
652
Views
25
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Randomized Trial of Zileuton for Treatment of COPD Exacerbations Requiring Hospitalization

Prescott G. WoodruffCorrespondence[email protected]
,
Richard K. AlbertDepartment of Medicine, Denver Health Medical Ctr, Denver, Colorado, USA,
,
William C. BaileyDivision of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Alabama, USA,
,
Richard CasaburiDivision of Respiratory and Critical Care Physiology and Medicine, Harbor-UCLA Medical Center, Torrance, California, USA,
,
John E. ConnettDivision of Biostatistics, University of Minnesota, School of Public Health, Minneapolis, Minnesota, USA,
,
John A.D. Cooper Jr.
,
Gerard J. CrinerDivision of Pulmonary and Critical Care Medicine, Temple University, Philadelphia, Pennsylvania, USA,
,
Jeffrey L. CurtisDivision of Pulmonary and Critical Care Medicine, Ann Arbor VA Healthsystem, Michigan, USA,
,
Mark T. Dransfield
,
Meilan K. HanDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA,
,
Sarah M. HarndenDivision of Biostatistics, University of Minnesota, School of Public Health, Minneapolis, Minnesota, USA,
,
Victor KimDivision of Pulmonary and Critical Care Medicine, Temple University, Philadelphia, Pennsylvania, USA,
,
Nathaniel MarchettiDivision of Pulmonary and Critical Care Medicine, Temple University, Philadelphia, Pennsylvania, USA,
,
Fernando J. MartinezDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA,
,
Charlene E. McEvoyHealthPartners, Division of Pulmonary Medicine, St. Paul, Minnesota, USA,
,
Dennis E. NiewoehnerPulmonary Section, University of Minnesota, VA Medical Center, Minneapolis, Minnesota, USA,
,
John J. ReillyDivision of Pulmonary and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA,
,
Kathryn RicePulmonary Section, University of Minnesota, VA Medical Center, Minneapolis, Minnesota, USA,
,
Paul D. ScanlonDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA,
,
Steven M. ScharfDivision of Pulmonary and Critical Care Medicine, University of Maryland, Baltimore, Maryland, USA,
,
Frank C. SciurbaDivision of Pulmonary and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA,
,
George R. WashkoDivision of Pulmonary & Critical Care Medicine, Brigham & Women's Hospital, Boston, Massachusetts, USA,
,
Stephen C. Lazarus
&
for the COPD Clinical Research NetworkDivision of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco, California, USA,
 show all
Pages 21-29 | Published online: 08 Feb 2011

REFERENCES

  • Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic Obstructive Pulmonary Disease Surveillance—United States, 1971–2002: CDC; 2002. MMWR Surveillance Summary No. 51(SS06).
  • Merrill CT, Elixhauser A. Hospitalization in the United States, 2002. Rockville, MD: Agency for Healthcare Research and Quality, 2005 HCUP Fact Book No. 6. AHRQ; 2005 No. 05- 0056.
  • Peters-Golden M. Expanding roles for leukotrienes in airway inflammation. Curr Allergy Asthma Rep 2008; 8(4):367–373.
  • Shindo K, Hirai Y, Fukumura M, Koide K. Plasma levels of leukotriene E4 during clinical course of chronic obstructive pulmonary disease. Prostaglandins Leukot Essent Fatty Acids 1997; 56(3):213–217.
  • Hill AT, Campbell EJ, Bayley DL, Hill SL, Stockley RA. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med 1999; 160(6):1968–1975.
  • Crooks SW, Bayley DL, Hill SL, Stockley RA. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J 2000; 15(2):274–280.
  • Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003; 58(4):294–298.
  • Nannini LJ, Jr., Flores DM. Bronchodilator effect of zafirlukast in subjects with chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2003; 16(5):307–311.
  • Montuschi P, Kharitonov SA, Ciabattoni G, Barnes PJ. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003; 58(7):585–588.
  • Seggev JS, Thornton WH, Jr., Edes TE. Serum leukotriene B4 levels in patients with obstructive pulmonary disease. Chest 1991; 99(2):289–291.
  • Celik P, Sakar A, Havlucu Y, Yuksel H, Turkdogan P, Yorgancioglu A. Short-term effects of montelukast in stable patients with moderate to severe COPD. Respir Med 2005; 99(4):444–450.
  • Gompertz S, Stockley RA. A randomized, placebo-controlled trial of a leukotriene synthesis inhibitor in patients with COPD. Chest 2002; 122(1):289–294.
  • Camargo CA, Jr., Smithline HA, Malice MP, Green SA, Reiss TF. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 2003; 167(4):528–533.
  • Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, Anderson P, Morgan NA. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med 1999; 340(25):1941–1947.
  • Marian E, Baraldo S, Visentin A, Papi A, Saetta M, Fabbri LM, Maestrelli P. Up-regulated membrane and nuclear leukotriene B4 receptors in COPD. Chest 2006; 129(6):1523–1530.
  • Kostikas K, Gaga M, Papatheodorou G, Karamanis T, Orphanidou D, Loukides S. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005; 127(5):1553–1559.
  • Pinto-Plata VM, Livnat G, Girish M, Cabral H, Masdin P, Linacre P, Dew R, Kenney L, Celli BR. Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD. Chest 2007; 131(1):37–43.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.